| Financial Year |
March 31 2023 |
| Monetary Funds |
169,652,974.86 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,868,540.55 |
| Accounts Receivable |
132,194,543.73 |
| Advances to Suppliers |
57,976,236.39 |
| Other Receivables |
2,363,793.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
360,604,975.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
42,790,111.84 |
| Total Current Assets |
771,438,837.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
582,972,902.21 |
| Under-construction Projects |
41,412,518.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
44,626,058.59 |
| R&D expenses |
-- |
| Goodwill |
5,953,765.35 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
15,139,657.52 |
| Other Non-Current Assets |
7,622,358.35 |
| Sub-Total of Non-Current Assets |
698,299,931.56 |
| Total Assets |
1,469,738,769.53 |
| Short-Term Loans |
474,668,223.08 |
| Trading Financial liabilities |
-- |
| Notes Payable |
19,668,344.97 |
| Accounts Payable |
91,517,090.55 |
| Accounts Received In Advance |
84,958.07 |
| Employee Compensation Payable |
4,477,797.13 |
| Taxes Payable |
4,291,015.46 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,087,684.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
25,554,761.20 |
| Other Current Liabilities |
3,164,728.22 |
| Sub-Total of Current Liabilities |
627,514,602.85 |
| Long-term Loans |
27,023,607.95 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,415,304.88 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
82,414,777.76 |
| Total Liabilities |
709,929,380.61 |
| Paid-In Capital(Or Share Stock) |
152,852,499.00 |
| Capital Surplus |
428,082,337.07 |
| Surplus Reserve |
16,478,186.62 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
141,708,312.25 |
| Minority Stockholder's Interest |
21,194,115.23 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
738,615,273.69 |
| Owner's Equity（Stockholder's Equity） |
759,809,388.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,469,738,769.53 |
